2023-10-012024-09-302024-09-30false14378056SABIBA LTD2025-06-24falseiso4217:GBPxbrli:pure143780562023-10-01143780562024-09-30143780562023-10-012024-09-30143780562022-09-27143780562023-09-30143780562022-09-272023-09-3014378056bus:SmallEntities2023-10-012024-09-3014378056bus:AuditExempt-NoAccountantsReport2023-10-012024-09-3014378056bus:FullAccounts2023-10-012024-09-3014378056bus:PrivateLimitedCompanyLtd2023-10-012024-09-3014378056core:WithinOneYear2024-09-3014378056core:AfterOneYear2024-09-3014378056core:WithinOneYear2023-09-3014378056core:AfterOneYear2023-09-3014378056core:ShareCapital2024-09-3014378056core:SharePremium2024-09-3014378056core:RevaluationReserve2024-09-3014378056core:OtherReservesSubtotal2024-09-3014378056core:RetainedEarningsAccumulatedLosses2024-09-3014378056core:ShareCapital2023-09-3014378056core:SharePremium2023-09-3014378056core:RevaluationReserve2023-09-3014378056core:OtherReservesSubtotal2023-09-3014378056core:RetainedEarningsAccumulatedLosses2023-09-3014378056core:LandBuildings2024-09-3014378056core:PlantMachinery2024-09-3014378056core:Vehicles2024-09-3014378056core:FurnitureFittings2024-09-3014378056core:OfficeEquipment2024-09-3014378056core:NetGoodwill2024-09-3014378056core:IntangibleAssetsOtherThanGoodwill2024-09-3014378056core:ListedExchangeTraded2024-09-3014378056core:UnlistedNon-exchangeTraded2024-09-3014378056core:LandBuildings2023-09-3014378056core:PlantMachinery2023-09-3014378056core:Vehicles2023-09-3014378056core:FurnitureFittings2023-09-3014378056core:OfficeEquipment2023-09-3014378056core:NetGoodwill2023-09-3014378056core:IntangibleAssetsOtherThanGoodwill2023-09-3014378056core:ListedExchangeTraded2023-09-3014378056core:UnlistedNon-exchangeTraded2023-09-3014378056core:LandBuildings2023-10-012024-09-3014378056core:PlantMachinery2023-10-012024-09-3014378056core:Vehicles2023-10-012024-09-3014378056core:FurnitureFittings2023-10-012024-09-3014378056core:OfficeEquipment2023-10-012024-09-3014378056core:NetGoodwill2023-10-012024-09-3014378056core:IntangibleAssetsOtherThanGoodwill2023-10-012024-09-3014378056core:ListedExchangeTraded2023-10-012024-09-3014378056core:UnlistedNon-exchangeTraded2023-10-012024-09-3014378056core:MoreThanFiveYears2023-10-012024-09-3014378056core:Non-currentFinancialInstruments2024-09-3014378056core:Non-currentFinancialInstruments2023-09-3014378056dpl:CostSales2023-10-012024-09-3014378056dpl:DistributionCosts2023-10-012024-09-3014378056core:LandBuildings2023-10-012024-09-3014378056core:PlantMachinery2023-10-012024-09-3014378056core:Vehicles2023-10-012024-09-3014378056core:FurnitureFittings2023-10-012024-09-3014378056core:OfficeEquipment2023-10-012024-09-3014378056dpl:AdministrativeExpenses2023-10-012024-09-3014378056core:NetGoodwill2023-10-012024-09-3014378056core:IntangibleAssetsOtherThanGoodwill2023-10-012024-09-3014378056dpl:GroupUndertakings2023-10-012024-09-3014378056dpl:ParticipatingInterests2023-10-012024-09-3014378056dpl:GroupUndertakingscore:ListedExchangeTraded2023-10-012024-09-3014378056core:ListedExchangeTraded2023-10-012024-09-3014378056dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-10-012024-09-3014378056core:UnlistedNon-exchangeTraded2023-10-012024-09-3014378056dpl:CostSales2022-09-272023-09-3014378056dpl:DistributionCosts2022-09-272023-09-3014378056core:LandBuildings2022-09-272023-09-3014378056core:PlantMachinery2022-09-272023-09-3014378056core:Vehicles2022-09-272023-09-3014378056core:FurnitureFittings2022-09-272023-09-3014378056core:OfficeEquipment2022-09-272023-09-3014378056dpl:AdministrativeExpenses2022-09-272023-09-3014378056core:NetGoodwill2022-09-272023-09-3014378056core:IntangibleAssetsOtherThanGoodwill2022-09-272023-09-3014378056dpl:GroupUndertakings2022-09-272023-09-3014378056dpl:ParticipatingInterests2022-09-272023-09-3014378056dpl:GroupUndertakingscore:ListedExchangeTraded2022-09-272023-09-3014378056core:ListedExchangeTraded2022-09-272023-09-3014378056dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-09-272023-09-3014378056core:UnlistedNon-exchangeTraded2022-09-272023-09-3014378056core:NetGoodwill2024-09-3014378056core:IntangibleAssetsOtherThanGoodwill2024-09-3014378056core:LandBuildings2024-09-3014378056core:PlantMachinery2024-09-3014378056core:Vehicles2024-09-3014378056core:FurnitureFittings2024-09-3014378056core:OfficeEquipment2024-09-3014378056core:AfterOneYear2024-09-3014378056core:WithinOneYear2024-09-3014378056core:ListedExchangeTraded2024-09-3014378056core:UnlistedNon-exchangeTraded2024-09-3014378056core:ShareCapital2024-09-3014378056core:SharePremium2024-09-3014378056core:RevaluationReserve2024-09-3014378056core:OtherReservesSubtotal2024-09-3014378056core:RetainedEarningsAccumulatedLosses2024-09-3014378056core:NetGoodwill2023-09-3014378056core:IntangibleAssetsOtherThanGoodwill2023-09-3014378056core:LandBuildings2023-09-3014378056core:PlantMachinery2023-09-3014378056core:Vehicles2023-09-3014378056core:FurnitureFittings2023-09-3014378056core:OfficeEquipment2023-09-3014378056core:AfterOneYear2023-09-3014378056core:WithinOneYear2023-09-3014378056core:ListedExchangeTraded2023-09-3014378056core:UnlistedNon-exchangeTraded2023-09-3014378056core:ShareCapital2023-09-3014378056core:SharePremium2023-09-3014378056core:RevaluationReserve2023-09-3014378056core:OtherReservesSubtotal2023-09-3014378056core:RetainedEarningsAccumulatedLosses2023-09-3014378056core:NetGoodwill2022-09-2714378056core:IntangibleAssetsOtherThanGoodwill2022-09-2714378056core:LandBuildings2022-09-2714378056core:PlantMachinery2022-09-2714378056core:Vehicles2022-09-2714378056core:FurnitureFittings2022-09-2714378056core:OfficeEquipment2022-09-2714378056core:AfterOneYear2022-09-2714378056core:WithinOneYear2022-09-2714378056core:ListedExchangeTraded2022-09-2714378056core:UnlistedNon-exchangeTraded2022-09-2714378056core:ShareCapital2022-09-2714378056core:SharePremium2022-09-2714378056core:RevaluationReserve2022-09-2714378056core:OtherReservesSubtotal2022-09-2714378056core:RetainedEarningsAccumulatedLosses2022-09-2714378056core:AfterOneYear2023-10-012024-09-3014378056core:WithinOneYear2023-10-012024-09-3014378056core:Non-currentFinancialInstrumentscore:CostValuation2023-10-012024-09-3014378056core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-10-012024-09-3014378056core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-10-012024-09-3014378056core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-10-012024-09-3014378056core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-10-012024-09-3014378056core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-10-012024-09-3014378056core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-10-012024-09-3014378056core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-10-012024-09-3014378056core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-10-012024-09-3014378056core:Non-currentFinancialInstrumentscore:CostValuation2024-09-3014378056core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-3014378056core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-3014378056core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-3014378056core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-3014378056core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-3014378056core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-3014378056core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-3014378056core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-3014378056core:Non-currentFinancialInstrumentscore:CostValuation2023-09-3014378056core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-09-3014378056core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-09-3014378056core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-09-3014378056core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-09-3014378056core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-09-3014378056core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-09-3014378056core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-09-3014378056core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-09-3014378056bus:Director12023-10-012024-09-30

SABIBA LTD

Registered Number
14378056
(England and Wales)

Unaudited Financial Statements for the Year ended
30 September 2024

SABIBA LTD
Company Information
for the year from 1 October 2023 to 30 September 2024

Director

AHMADOVA, Sabina Sabir

Registered Address

61 Bridge Street, Kington,
Bridge Street
Kington
HR5 3DJ

Registered Number

14378056 (England and Wales)
SABIBA LTD
Balance Sheet as at
30 September 2024

Notes

2024

2023

£

£

£

£

Current assets
Cash at bank and on hand416485
416485
Creditors amounts falling due within one year3(5,801)(2,522)
Net current assets (liabilities)(5,385)(2,037)
Total assets less current liabilities(5,385)(2,037)
Net assets(5,385)(2,037)
Capital and reserves
Called up share capital1010
Profit and loss account(5,395)(2,047)
Shareholders' funds(5,385)(2,037)
The financial statements were approved and authorised for issue by the Director on 24 June 2025, and are signed on its behalf by:
AHMADOVA, Sabina Sabir
Director
Registered Company No. 14378056
SABIBA LTD
Notes to the Financial Statements
for the year ended 30 September 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The critical judgements made by management that have a significant effect on the amounts recognised in the financial statements are described below.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

20242023
Average number of employees during the year00
3.Creditors: amounts due within one year

2024

2023

££
Bank borrowings and overdrafts45-
Amounts owed to related parties3,5961,502
Accrued liabilities and deferred income2,1601,020
Total5,8012,522
4.Related party transactions
During the year, the company received an interest free loan from the director amounting to £3,596 (2023: £1,502)